AFP on MSN43m
Asian stocks mixed as tariff fears return, new AI programme emerges
Asian markets fluctuated Monday on fresh trade fears after Donald Trump's decision to impose huge tariffs on Colombia, in ...
Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...